Purchase Order 75N95025P00426
Award Date
9/22/25
Potential Completion Date
9/21/28
Potential Value
$21K
Federal Agency
National Institute on Drug Abuse
Awardee
Certara USA Inc.
Ultimate Awardee
Not listed
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Wayne, PA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Certara USA Inc. is for toxicology consulting services to support the National Institute of Neurological Disorders and Stroke (NINDS), the National Institutes of Health (NIH) Blueprint Neurotherapeutics Network (BPN), the NIH Helping to End Addiction Long-term (HEAL) Initiative, and other NIH neuroscience-focused drug discovery and development programs. The $2,167,500.00 purchase order contract has a completion date of September 19, 2025 and is not a set-aside...
The federal contract award, valued at $10,743.00, was issued by the National Cancer Institute (NCI) to Certara USA Inc., a leading global technology-enabled drug development and drug safety consultancy, for the procurement of software licenses. The contract is a firm-fixed price purchase order with no set-aside designation and an ultimate completion date of August 13, 2025. Certara USA Inc. has received numerous prime contract awards from the NCI, Food and Drug Administration (FDA), and National...
This federal contract award provides small molecules and biologics toxicology consultant support services to the National Institute on Drug Abuse (NIDA), a civilian agency. The $28,000.00 purchase order contract was awarded to Toxstrategies, LLC, a for-profit small business, on September 22, 2025 with a completion date of September 21, 2028. The work is to be performed in Katy, Texas. The original solicitation was a pre-solicitation notice from the National Institute of Neurological Disorders...
The U.S. National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services' National Institutes of Health, awarded a $19,600.00 Purchase Order contract to Lin Jiunn, a small business located in Ambler, Pennsylvania. The contract is for a Subject Matter Expert Consultant in Drug Metabolism Pharmacokinetics (DMPK) to support NIDA's NIH Blueprint Neurotherapeutics Network program. The contract has a one-year base period with an estimated minimum of 20 annual hours and a...
The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $54,000.00 labor-hour purchase order contract to RPK Associates, LLC, a small business, for pharmaceutics formulation and chemistry manufacturing and controls (CMC) consulting services for small molecules and/or biologics. The contract has a base period from September 20, 2025, through September 19, 2026, with optional hours up to 800 total hours per consultant annually. The services...
The U.S. National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a $10,000.00 labor-hour purchase order contract to Christoph Kahl, a small business located in Thousand Oaks, California. The contract is for pharmaceutics formulation and chemistry manufacturing and controls (CMC) consulting services to support NIDA's drug discovery and development programs, including the NIH Blueprint Neurotherapeutics, Help End Addiction Longterm...
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc. The $101,372.00 firm fixed-price delivery order contract is part of the NIH Bioanalysis Testing Services 2015-2020 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. Under this award, Pharmaron will provide a range of preclinical research services to support NIDA's drug discovery and development initiatives,...
This federal contract award is a delivery order under a larger contract vehicle, with Research Triangle Institute (RTI) International as the prime contractor. The contract is with the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The award, valued at $376,358.00, is for the synthesis and distribution of drugs of abuse and related compounds over a one-year period from June 16, 2024 to June 15, 2025, with a total period of...
The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, awarded a $34,450.00 firm-fixed-price purchase order contract to Optibrium Limited, a foreign-owned for-profit organization based in the United Kingdom. The contract is for a software and database subscription for the StarDrop product, which supports the National Center for Advancing Translational Sciences' (NCATS) drug discovery research capabilities. This sole-source award was made...
The U.S. National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services' National Institutes of Health, awarded a $24,000.00 Labor Hour Purchase Order contract to Pearson Pharma Partners, a small business, to provide a Subject Matter Expert Consultant in Drug Metabolism Pharmacokinetics (DMPK) to support the NIH Blueprint Neurotherapeutics Network program. The one-year base period contract has an estimated minimum of 20 annual hours and a not-to-exceed maximum of...